Study to Evaluate the Sexual Functioning of Healthy Adults After Receiving Vilazodone, Paroxetine or Placebo

Completed · Phase 1 · Has a placebo group

Conditions studied: Healthy

In brief

To compare the effects of vilazodone, paroxetine and placebo on sexual function in sexually active healthy adults.

Key facts

Study ID

NCT02097147

Run by

Forest Laboratories

People needed

202

Starts

2014-03-01

Expected to finish

2014-11-01

Last updated by the study team

2015-02-12

Who can join

Age: 18 and older, up to 45. Sex: any. Healthy volunteers: accepted.

You may qualify if…

• Healthy male or female, aged 18 through 45 years, inclusive
• Currently sexually active
• If female, non pregnant and agree to use acceptable for of contraception during
• If male, be sterile or have partner use contraception.

You may not qualify if…

• Have sexual dysfunction
• Have history of diagnosis or treatment of any disorder related to sexual functioning.
• Clinically significant disease state, in the opinion of the examining physician, in any body system
• History of alcohol or other substance abuse or dependence within the previous 5 years

Where it is running

• Forest Investigative Site 001 — Miami, Florida, United States
• Forest Investigative Site 002 — Overland Park, Kansas, United States
• Forest Investigative Site 003 — Saint Paul, Minnesota, United States
• Forest Investigative Site 004 — Charlottesville, Virginia, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.